Blueprint Medicines Corp Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Blueprint Medicines Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Blueprint Medicines Corp for March 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 51.52 | 774 | 39,876 | 15,250 | 16 K to 15.3 K (-4.83 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 53.43 | 241 | 12,877 | 16,024 | 16.3 K to 16 K (-1.48 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 55.14 | 199 | 10,973 | 16,265 | 16.5 K to 16.3 K (-1.21 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 19,920 | 175,296 | 87,170 | |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 80 | 150 | 0 | |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 20,000 | 37,400 | 173,903 | |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 50.40 | 3,337 | 168,185 | 141,434 | 144.8 K to 141.4 K (-2.31 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 51.30 | 8,850 | 454,005 | 144,771 | 153.6 K to 144.8 K (-5.76 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 52.11 | 2,100 | 109,431 | 153,621 | 155.7 K to 153.6 K (-1.35 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 53.54 | 1,936 | 103,653 | 155,721 | 157.7 K to 155.7 K (-1.23 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 54.62 | 3,293 | 179,864 | 157,657 | 161 K to 157.7 K (-2.05 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 55.34 | 484 | 26,785 | 160,950 | 161.4 K to 161 K (-0.30 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 19,920 | 175,296 | 161,434 | 141.5 K to 161.4 K (+14.08 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 80 | 150 | 141,514 | 141.4 K to 141.5 K (+0.06 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 20,000 | 37,400 | 141,434 | 121.4 K to 141.4 K (+16.47 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 51.94 | 253 | 13,141 | 9,984 | 10.2 K to 10 K (-2.47 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 51.97 | 2,277 | 118,336 | 121,434 | 123.7 K to 121.4 K (-1.84 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 51.97 | 536 | 27,856 | 18,964 | 19.5 K to 19 K (-2.75 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 51.99 | 536 | 27,867 | 16,464 | 17 K to 16.5 K (-3.15 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | Landsittel Michael | Chief Financial Off ... | Sell | S | 51.97 | 400 | 20,788 | 17,350 | 17.8 K to 17.4 K (-2.25 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Sell | S | 51.98 | 617 | 32,072 | 21,683 | 22.3 K to 21.7 K (-2.77 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | Murray Christopher K. | SVP, Technical Oper ... | Sell | S | 51.94 | 402 | 20,880 | 13,848 | 14.3 K to 13.8 K (-2.82 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Sell | S | 51.96 | 135 | 7,015 | 20,365 | 20.5 K to 20.4 K (-0.66 %) |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 16.28 | 4,644 | 75,604 | 3,145 | |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | A | 54.13 | 28,500 | 1,542,705 | 28,500 | |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 16.28 | 4,644 | 75,604 | 43,509 | 38.9 K to 43.5 K (+11.95 %) |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Grant | A | 0.00 | 14,250 | 0 | 38,865 | 24.6 K to 38.9 K (+57.89 %) |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Option Exercise | A | 54.13 | 28,500 | 1,542,705 | 28,500 | |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Grant | A | 0.00 | 14,250 | 0 | 20,500 | 6.3 K to 20.5 K (+228.00 %) |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | A | 54.13 | 90,000 | 4,871,700 | 90,000 | |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Grant | A | 0.00 | 45,000 | 0 | 123,711 | 78.7 K to 123.7 K (+57.17 %) |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Option Exercise | A | 54.13 | 28,500 | 1,542,705 | 28,500 | |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Grant | A | 0.00 | 14,250 | 0 | 22,300 | 8.1 K to 22.3 K (+177.02 %) |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Landsittel Michael | Chief Financial Off ... | Option Exercise | A | 54.13 | 25,000 | 1,353,250 | 25,000 | |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Landsittel Michael | Chief Financial Off ... | Grant | A | 0.00 | 12,500 | 0 | 17,750 | 5.3 K to 17.8 K (+238.10 %) |